Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | angiotensin II receptor, type 1 | Starlite/ChEMBL | No references |
Rattus norvegicus | Angiotensin II receptor (AT-1) type-1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.1196 | 0.6863 | 0.7383 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.1196 | 0.6863 | 1 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.1196 | 0.6863 | 0.7383 |
Mycobacterium tuberculosis | Probable conserved transmembrane protein | 0.0232 | 0.1007 | 0.1835 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.1196 | 0.6863 | 1 |
Entamoeba histolytica | carbonic anhydrase, putative | 0.1425 | 0.826 | 1 |
Schistosoma mansoni | carbonic anhydrase | 0.1425 | 0.826 | 1 |
Mycobacterium ulcerans | carbonic anhydrase | 0.1425 | 0.826 | 0.9536 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1491 | 0.8661 | 1 |
Onchocerca volvulus | 0.0201 | 0.0817 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.1491 | 0.8661 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0547 | 0.2921 | 0.5 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase CanB | 0.0892 | 0.5015 | 0.9256 |
Mycobacterium tuberculosis | Probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase) | 0.0766 | 0.4252 | 0.7843 |
Mycobacterium ulcerans | carbonic anhydrase | 0.1491 | 0.8661 | 1 |
Echinococcus granulosus | carbonic anhydrase | 0.0547 | 0.2921 | 0.4243 |
Leishmania major | carbonic anhydrase family protein, putative | 0.1425 | 0.826 | 1 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.1196 | 0.6863 | 0.5 |
Echinococcus granulosus | carbonic anhydrase II | 0.1196 | 0.6863 | 1 |
Plasmodium falciparum | carbonic anhydrase | 0.0547 | 0.2921 | 0.5 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.1196 | 0.6863 | 0.5568 |
Mycobacterium leprae | Probable transmembrane transport protein | 0.0232 | 0.1007 | 0.1219 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.1196 | 0.6863 | 0.5 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase | 0.0958 | 0.5417 | 1 |
Onchocerca volvulus | Putative sulfate transporter | 0.0201 | 0.0817 | 1 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.1196 | 0.6863 | 0.5568 |
Wolbachia endosymbiont of Brugia malayi | 2,3,4,5-tetrahydropyridine-2,6-carboxylate N-succinyltransferase | 0.0069 | 0.0016 | 0.5 |
Echinococcus granulosus | carbonic anhydrase | 0.0547 | 0.2921 | 0.4243 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.1425 | 0.826 | 1 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.1196 | 0.6863 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | N-acetylglucosamine-1-phosphate uridyltransferase | 0.0069 | 0.0016 | 0.5 |
Echinococcus multilocularis | carbonic anhydrase II | 0.1196 | 0.6863 | 1 |
Echinococcus granulosus | carbonic anhydrase | 0.0547 | 0.2921 | 0.4243 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 14.6 nM | Binding affinity expressed as IC50 to the Angiotensin II receptor, type 1, from rat liver membrane | ChEMBL. | 7562906 |
IC50 (binding) | = 14.6 nM | Binding affinity expressed as IC50 to the Angiotensin II receptor, type 1, from rat liver membrane | ChEMBL. | 7562906 |
IC50 (binding) | = 14.6 nM | Antagonist activity at angiotensin 2 type-1 receptor (unknown origin) | ChEMBL. | No reference |
log(1/C) (binding) | = -1.164 | Antagonist activity at angiotensin 2 type-1 receptor (unknown origin) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.